It gives high response ratesand improved survival parameters in metastatic colorectalcancer patients. The objective response rate was 24% as asingle agent in second line intravenous chemotherapy [10],and around 50% in first line combined with 5-fluorouracil(5-FU) and folinic acid at a dose intensity of 40–50 mg/m2/week [11, 12].